Pyoderma gangrenosum with primary sclerosing cholangitis-associated colitis successfully treated with concomitant granulocyte and monocyte adsorption apheresis with corticosteroids-Reference-Cited by-同舟云学术

Pyoderma gangrenosum with primary sclerosing cholangitis-associated colitis successfully treated with concomitant granulocyte and monocyte adsorption apheresis with corticosteroids

Published:2021-06-08 Issue:5 Volume:14 Page:1561-1566
ISSN:1865-7257
Container-title:Clinical Journal of Gastroenterology
language:en
Short-container-title:Clin J Gastroenterol

Author:

Kawai Munenori^ORCID,Kawanami Chiharu,Fukuda Akihisa,Seno Hiroshi

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12328-021-01460-0.pdf

Reference31 articles.

1. Crowson AN, Mihm MC Jr, Magro C. Pyoderma gangrenosum: a review. J Cutan Pathol. 2003;30:97–107.

2. Callen JP. Pyoderma gangrenosum. Lancet. 1998;351:581–5.

3. Teagle A, Hargest R. Management of pyoderma gangrenosum. J R Soc Med. 2014;107(6):228–36.

4. Schøsler L, Fogh K, Bech R. Pyoderma gangrenosum: a retrospective study of clinical charac-teristics, comorbidities, response to treatment and mortality related to prednisone dose. Acta Derm Venereol. 2021;101:adv00431.

5. Bernstein CN, Blanchard JF, Yu N, et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96:1116–22.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A retrospective study to investigate the efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with primary sclerosing cholangitis with ulcerative colitis;Journal of Clinical Apheresis;2023-11-21

2. Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases – a case report and literature review;Therapeutic Advances in Chronic Disease;2023-01

3. Granulocyte Apheresis: Can It Be Associated with Anti PD-1 Therapy for Melanoma?;Medicina;2022-10-06

4. Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease;WORLD J CLIN CASES;2022

5. Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease;World Journal of Clinical Cases;2022-07-26